Theravectys
Phase 1/2Theravectys - We support patients and healthcare providers by developing prophylactic and therapeutic immunotherapies. Immunize-Treat-Cure
Founded
2004
Focus
Vaccines
About
Theravectys - We support patients and healthcare providers by developing prophylactic and therapeutic immunotherapies. Immunize-Treat-Cure
Funding History
4Total raised: $69.4M
Series C$33MBpifranceJun 15, 2015
Grant$6.4MEuropean CommissionJun 15, 2014
Series B$20MUndisclosedJun 15, 2013
Series A$10MUndisclosedJun 15, 2010
Company Info
TypePrivate
Founded2004
LocationParis, France
StagePhase 1/2
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile